DePuy Synthes, Stryker and Arthrex, Inc. will be Dominating the Switzerland Foot and Ankle Devices in 2022

Switzerland Foot and Ankle Devices Market is expected to grow with the CAGR of 4.8% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/switzerland-foot-and-ankle-devices-market

Switzerland foot and ankle devices market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in Switzerland foot and ankle devices market are introducing wide range of product portfolio. This helped companies to maximize the sales of orthopaedic surgical energy devices and product portfolio.

For instance,

  • In February 2022, Johnson & Johnson Medical Devices Companies announced that DePuy Synthes had acquired CrossRoads that provide a broad range of procedure-specific, sterile-packed implants and instrumentation systems that are cleared for lower extremity indications. Thus, by this acquisition, DePuy will have an extreme growth and enhancement in its foot and ankle segment, eventually increasing its overall revenue.

DePuy Synthes (a subsidiary of Johnson & Johnson Services, Inc) is the dominating player in Switzerland foot and ankle devices market and the other players are Smith+Nephew, Össur, OTTOBOCK, Globus Medical, Medartis AG, GROUP FH ORTHO, Stryker, Zimmer Biomet., Arthrex, Inc., DJO, LLC, and acumed, among others.

DePuy Synthes

DePuy Synthes was founded in 1895 and is headquartered in Pennyslavania, the U.S. The company provides one of the most comprehensive Orthopedics portfolios in the world that helps heal and restore movement for the millions of patients. The product categories are craniomaxillofacial, digital and enabling technologies, foot & ankle, hand and wrist, hip, knee, power tools, shoulder and elbow, spine, thorax services. The market focused category is hip and knee.

For instance,

  • In February 2022, Johnson & Johnson Medical Devices Companies announced that DePuy Synthes had acquired CrossRoads that provide a broad range of procedure-specific, sterile-packed implants and instrumentation systems that are cleared for lower extremity indications. Thus, by this acquisition, DePuy will have an extreme growth and enhancement in its foot and ankle segment, eventually increasing its overall revenue.

The company has presence in North America, South America, Asia-Pacific, Europe, Middle East and Africa.

Stryker

Stryker was founded in 1941 and is headquartered in Michigan, the U.S. The company is focused on offering innovative products and services in medical and surgical, neurotechnology, orthopaedics and spine that help improve patient and hospital outcomes. The product categories are Advanced Digital Healthcare, Craniomaxillofacial, Foot and Ankle, Joint Replacement, Spine, Sports Medicine, Trauma & Extremities, Upper Extremities. The market focused category is foot and ankle.

For instance,

  • In May 2020, Stryker announced its acquisition with Wright Medical to showcase its new, combined foot and ankle portfolio incorporating Wright Medical’s products. This acquisition helped the company grow its product portfolio and introduce new foot and ankle products worldwide.

The subsidiaries are Alcott Indemnity Company (Vermont), Applied Medical Recovery, Inc. (Arizona), Applied Medical Technologies, LLC (Arizona) among others.

Arthrex, Inc.

Arthrex, Inc. was founded in 1981 and is headquartered in Florida, the U.S. The company is focused on product development and medical education in orthopaedics. The company offers range of product categories such as Shoulder, Knee, Elbow, Hand & Wrist, Foot & Ankle, Hip, Orthobiologics, Imaging & Resection, Trauma, Spine, Arthroplasty Knee, and Arthroplasty Shoulder. The market focused category is foot and ankle.

The company has global presence in North America, Europe, Middle East & Africa, Asia-Pacific, South America and Australia. The subsidiaries are Arthrex Australia Pty Ltd. (Australia), Arthrex Japan G.K. (Japan), Arthrex Korea Ltd. (Korea), Arthrex New Zealand Limited (New Zealand), and Arthrex Shanghai Co., Ltd. (Shanghai) among others.